Abstract Snake venoms are mixtures of bioactive proteins and peptides that exhibit diverse biochemical activities. This wide array of pharmacologies associated with snake venoms has made them attractive sources for research into potentially novel therapeutics, and several venom-derived drugs are now in use. In the current study we performed a broad screen of a variety of venoms (61 taxa) from the major venomous snake families (Viperidae, Elapidae and ''Colubridae'') in order to examine cytotoxic effects toward MCF-7 breast cancer cells and A-375 melanoma cells. MTT cell viability assays of cancer cells incubated with crude venoms revealed that most venoms showed significant cytotoxicity. We further investigated venom from the Red-bellied Blacksnake (Pseudechis porphyriacus); venom was fractionated by ion exchange fast protein liquid chromatography and several cytotoxic components were isolated. SDS-PAGE and MALDI-TOF mass spectrometry were used to identify the compounds in this venom responsible for the cytotoxic effects. In general, viper venoms were potently cytotoxic, with MCF-7 cells showing greater sensitivity, while elapid and colubrid venoms were much less toxic; notable exceptions included the elapid genera Micrurus, Naja and Pseudechis, which were quite cytotoxic to both cell lines. However, venoms with the most potent cytotoxicity were often not those with low mouse LD 50 s, including some dangerously venomous viperids and Australian elapids. This study confirmed that many venoms contain cytotoxic compounds, including catalytic PLA 2 s, and several venoms also showed significant differential toxicity toward the two cancer cell lines. Our results indicate that several previously uncharacterized venoms could contain promising lead compounds for drug development.
Introduction
Snake venoms contain a broad diversity of organic and inorganic compounds, consisting primarily of toxins, enzymes, and other bioactive peptides (Mackessy 2010a; Calvete et al. 2006; Lomonte et al. 2014) . Although a single venom may contain up to 100 different proteins (including isoforms), many of these compounds can be classified into a relatively limited number of protein families, including metalloproteases (Fox and Serrano 2005) , phosphodiesterases (Mackessy 1998) , phospholipases A 2 (Kini 2003; Huang and Mackessy 2004; Doley et al. 2010) , serine proteases (Mukherjee and Mackessy 2013) , acetylcholinesterases (Anderson and Dufton 1998) , disintegrins (Calvete et al. 2005; Saviola et al. 2013) , and three-finger toxins (such as a-neurotoxins and cardiotoxins: Doley et al. 2008; Kini 2002; Kini and Doley 2010; Nirthanan and Gwee 2004) . Millions of years of evolution have resulted in molecules with incredible selectivity for various physiological targets, leading to rapid immobilization and death of prey. However, the great diversity of molecules and biochemical activities found in snake venoms also makes these varied and complex mixtures attractive in the search for novel therapeutics.
The use of toxins as potential drugs has been a growing area of research in the last decade (Fox and Serrano 2007; Vonk et al. 2011) , and numerous promising drugs have already been developed from snake venom proteins and peptides, with more currently under investigation (Earl et al. 2012; Fox and Serrano 2007; Koh and Kini 2012; Vink et al. 2012; Takacs and Nathan 2014) . Classically, venom from Bothrops jararaca contributed to the development of the angiotensin-converting enzyme inhibitors, which are now widely used in the treatment of hypertension and kidney disease (Ferreira 1965; Ferreira et al. 1970; Koh and Kini 2012) . Not surprisingly, several snake venom-derived drugs utilized for anticoagulation and hemostasis have also been developed. For example, the platelet receptor glycoprotein IIb/IIIa (integrin a IIb b 3 ) antagonist eptifibatide is derived from a disintegrin isolated from Sistrurus miliarius barbouri venom (Kereiakes et al. 1996) , and several procoagulant drugs are currently under development (Earl et al. 2012) . Additionally, venom disintegrins, which act by binding to and modulating the functions of integrins (Kamiguti et al. 1998) , have demonstrated promising anti-angiogenic (Brown et al. 2008) , anti-tumor (Swenson et al. 2005; Sánchez et al. 2009 ) and anti-metastatic effects (Lucena et al. 2011; McLane et al. 2008; Tian et al. 2007) .
Although significant research has continued to examine novel sources for potential cancer treatments, many therapies are non-specific and often have severe side effects. Snake and other animal venoms comprise unique libraries of biological compounds offering vast arrays of pharmacological activities that recognize certain receptors with high specificity. In return, isolated venom compounds may be utilized in treatments for not only cancer, but disorders such as arthritis and thrombosis as well (Pal et al. 2002 ). In the current study, using a diverse collection of snake venoms representing the three major clades of venomous snakes (Elapidae, Viperidae and the rearfanged ''Colubridae''), we examined cytotoxic effects toward human breast (MCF-7) and melanoma (A-375) cancer cell lines. Pseudechis porphyriacus venom was chosen for further analysis, based on initial cytotoxicity assays, and isolation of two protein fractions is presented as an example of the cytotoxic effects of specific venom proteins. The methodologies we utilized in this study represent an effective approach for the initial screening of snake venoms and have the potential to uncover novel compounds (Chaim-Matyas and Ovadia 1987; El-Refael and Sarkar 2009; Oron et al. 1992) , and many of the venoms analyzed here have not been previously investigated.
Materials and methods

Venom extraction and preparation
Venoms were manually extracted from snakes using established methods (Mackessy 1988; Hill and Mackessy 1997) , with all procedures approved by the University of Northern Colorado Institutional Animal Care and Use Committee (protocols 0702 and 0901C). Venoms were then centrifuged, lyophilized and stored frozen at -20°C until use. Samples were reconstituted in ddH 2 O at 4 mg/mL, centrifuged at 10,0009g to pellet insoluble debris, and the supernatant was used in all experiments. Red-bellied Black Snake (P. porphyriacus) venom was collected using similar methods and was a gift of Venom Supplies Pty. Ltd. (Tanandu, AU). Venoms from most Bothrops species were a gift of Dr. C. Ownby. Specific materials were purchased from suppliers as noted below; all other biochemicals (analytical grade or better) were obtained from Sigma Chemical Co. (St. Louis, MO, USA).
Cell culture and viability assays
All cancer cells, media, cell viability assay kits, and fetal bovine serum were purchased from American Type Cell Culture (ATCC; Manassas, VA, USA).
MCF-7 human breast adenocarcinoma cells (ATCC HTB-22) were maintained in Eagle's minimum essential medium (EMEM) with 0.01 mg/mL bovine insulin and 10 % fetal bovine serum. A-375 human malignant melanoma cells (ATCC CRL-1619) were cultured in Dulbecco's modified Eagle medium (DMEM) with 10 % fetal bovine serum. All cells were maintained in 75 mL flasks at\90 % confluence and incubated at 37°C with 5 % CO 2 in a humidified atmosphere. Cells were subcultivated according to instructions from ATCC, using trypsin-EDTA (0.05 % Trypsin and 0.02 % EDTA; ATCC PCS-999-003) and cryopreserved using 5 % dimethyl sulfoxide (DMSO) in the appropriate growth medium.
Cytotoxicity of various crude venoms was examined using the colorimetric MTT [3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-teyrazolium bromide] assay, where cleavage of MTT by metabolically active cells produces a purple formazan product (Mosmann 1983) . The amount of formazan formed is directly proportional to the number of viable cells, which can then be quantified at 570 nm. For all assays, one hundred lL aliquots of cells at a concentration of 10 6 cells/mL (MCF-7 cells) or 5 9 10 5 cells/mL (A-375 cells) were plated into 96-well plates and treated with venom (20 lg in 5 lL) or an identical volume of PBS as the control, in a single-blind fashion. Cells were incubated with venom or control treatments for 24 h and then 10 lL/well of MTT reagent (ATCC) was added. Cells were then returned to the incubator for 2 h before being treated with 100 lL of detergent reagent (ATCC) to rupture cells and dissolve formazan into a colored solution. Plates were stored overnight in the dark at room temperature. Finally, data were collected using a SpectraMax-190 96 well plate reader (Molecular Devices, Sunnyvale, CA, USA) at 570 nm. A standard curve was generated for each assay performed, which consisted of 10 6 cells/mL (A-375: 5 9 10 5 ) serially diluted 1:2 down to a concentration of 6.25 9 10 4 cells/mL. Linear regression analysis indicated a linear relationship between absorbance and cell density from 6. Venom samples from P. porphyriacus were fractionated by cation exchange liquid chromatography using an Ä KTA Purifier 900 (GE Biosciences, Inc. Piscataway, NJ, USA). Venom was solubilized in 20 mM MES HCl, pH 6.5, at a concentration of 12 mg/mL, vortexed, centrifuged at 10,0009g for 5 min, decanted and filtered through a 0.2 lm syringe filter. Five hundred lL (6 mg) of sample was injected into a Tricorn Mono S 5/50 GL column (GE Biosciences) at a flow rate of 1 mL/min, and the column was developed with a linear gradient of 20 mM MES HCl, pH 6.5 (buffer A) and 20 mM MES HCl with 2 M NaCl, pH 6.5, (buffer B): isocratic at 100 % buffer A for 10 min, then a linear gradient over 65 min to 20 % buffer B, followed by 20-100 % buffer B for 10 min, after which the mobile phase was returned to 100 % buffer A. Proteins were detected at 280 nm, collected with a Frac-920 fraction collector (GE Biosciences, Inc.) and frozen until further characterized.
Characterization of Pseudechis porphyriacus FPLC fractions
To estimate the number of proteins and their molecular masses, fractions obtained from the FPLC separation were characterized by reducing SDS polyacrylamide gel electrophoresis (SDS-PAGE) using 12 % NuPage Bis-Tris gels (Invitrogen Inc., San Diego, CA, USA). Venom fractions from the FPLC separation were dried with a Speed-Vac (Savant, Thermo Fisher Scientific, Waltham, MA, USA), re-solubilized in LDS buffer with 15 mM dithiothreitol (final concentration), heated at 70°C for 15 min and approximately 10 lg protein per lane was applied to the gel. Standards for estimating molecular mass (Mark 12 unstained standards) were purchased from Invitrogen. To estimate protein families and obtain more accurate molecular masses, FPLC fractions of peaks 1 and 13 (fractions 3 and 148) were analyzed using matrix-assisted laserdesorption ionization time-of-flight mass spectroscopy (MALDI-TOF-MS), as these peaks demonstrated the highest cytotoxicity towards cells. Ten lL of selected FPLC fractions was desalted and concentrated with a ZipTip C 4 micropipette tip. One lL of this sample was then spotted onto 1 lL sinapinic acid (10 mg/mL in 50 % acetonitrile with 0.1 % TFA) matrix. Data were collected using a Bruker (Billerica, MA, USA) Ultraflex mass spectrometer in linear mode. Samples were analyzed using a window of 5-16 kDa. Samples used in cytotoxicity assays were desalted and concentrated using spin columns (Amicon 3kD cutoff EMD Millipore Corp., Billerica, MA, USA), washed with 300 lL ddH 2 O 9 2 spins and then lyophilized.
Results
Effects of crude venom MTT cell proliferation assay results
In general, rattlesnake venoms (Crotalus and Sistrurus) were more toxic to both breast cancer and melanoma cells (Fig. 1a , b) than were those from elapid and colubrid snakes (Fig. 3a, b ). There were also, however, several highly cytotoxic elapid venoms and conversely, weakly cytotoxic rattlesnake venoms. Colubrid and elapid venoms demonstrated the highest degree of variation in cancer cell toxicity, though samples of some viperids (Agkistrodon, Atropoides, Bothriechis and Bothrops species) showed variable toxicities as well (Fig. 2a, b) . Most crude venoms studied showed significant cytotoxicity, particularly toward MCF-7 cells (Fig. 4) , although several, such as the hydrophiine elapids Hydrophis, Laticauda, Acanthophis and Notechis, did not (Figs. 3a, b, 4) . Several venoms used to treat the A-375 melanoma cells caused a dramatic change in cell phenotype, developing a distinctly rounded morphology after treatment (Fig. 5b) . In order to determine if cytotoxic effects were specific effects of the venoms or non-specific factors, dose-response curves were generated for four venoms of interest ( Fig. 6a-d) and IC 50 values were estimated. Crotalus oreganus cerberus and P. porphyriacus venoms demonstrated typical doseresponse curves (Fig. 6a, b) , in which increasing doses led to a decrease in viable cells, as indicated by decreased formazan production. However, venoms from both Bothrops alternatus and C. o. concolor, while exhibiting initial dose-dependent effects, appeared to reach a plateau at which greater doses of venom did not have significantly greater effects (Fig. 6c, d ). One venom which showed high levels of cytotoxicity (P. porphyriacus venom) was used as an example to demonstrate cytotoxicity of specific venom components.
FPLC fractionation of Pseudechis porphyriacus venom and characterization of fractions FPLC analysis of P. porphyriacus venom showed 13 well-defined peaks (Fig. 7a ) that were further subjected to reducing SDS-PAGE in order to estimate purity and mass of the compounds. Gel bands were classified into protein families (Fig. 8a ) based on previously identified venom proteins (see Mackessy 2010a) . All 13 peaks were tested for cytotoxic effects towards MCF-7 cells, with peaks 1 and 13 exhibiting the highest cytotoxicity and peaks 2, 4-6 and 8-10 showing intermediate toxicity (Fig. 8b) . The more potent cytotoxicity toward MCF-7 cells is likely due to the presence of a phospholipase A 2 (PLA 2 ) and a threefinger toxin (3FTx) in peak 1, and the PLA 2 present in peak 13 also appears to be quite cytotoxic. Peak 1 also may contain an acetylcholinesterase as well as small amounts of a non-enzymatic cysteine-rich secretory protein (CRiSP); however, due to the known biological activities of these compounds it is not likely that they were responsible for the cytotoxic affects seen here. SDS-PAGE indicated the possibility of trace amounts of a CRiSP in peak 13, but upon further investigation using MALDI-TOF-MS, we suspect that this peak contains primarily a single PLA 2 . Further MALDI-TOF-MS analysis of peak 1 and peak 13 confirmed that peak 1 contained numerous different compounds (at least five), with several in the 6-7 kDa range, indicating the presence of 3FTx isoforms, and several in the 13-14.5 kDa range, expected masses of PLA 2 isoforms (Fig. 8c) . Peak 13 apparently contains a single PLA 2 protein with a mass of 13,114.8 Da (Fig. 8 d) . The presence of this protein species, and the absence of any proteins in the 21-31 kDa range (data not shown), indicates that this peak does not contain a CRiSP, as CRiSPs typically ionize well and have masses of *25 kDa. 
Discussion
Research into venomous systems offers significant insights into the biological roles of venom compounds (Saviola et al. 2013 ) and provides useful information that can be utilized for effectively treating human snakebite ). In addition, venom research provides potential avenues for novel drug discovery and design (Fox and Serrano 2007; Vonk et al. 2011) . Venom composition varies between and among species depending on several factors, such as phylogenetic affinities (Mackessy 2010a) , geographic localities (Alape-Girón et al. 2008; Núñez et al. 2009 ), snake age (Mackessy 1988 (Mackessy , 1993 Mackessy et al. 2003; Calvete 2010) and diet (Gibbs and Mackessy 2009; Barlow et al. 2009 ). These often significant differences in venom composition, coupled with Thirteen well-resolved peaks were observed diverse and potent biological activities, make snake venoms attractive sources as pharmacological tools for understanding vertebrate physiological pathways and human diseases. As venoms are proving to be a excellent source of natural compounds exhibiting cytotoxic (Yalcın et al. 2014) , apopototic (Samel et al. 2012 ) and anti-tumor (Lin et al. 2010 ) effects towards numerous cancerous cell lines, continued research may identify novel therapeutics for cancers or other diseases.
In the current study we examined the cytotoxic effects toward both MFC-7 breast cancer and A-375 melanoma cell lines of venoms representing three very different families of snakes, from the highly venomous front-fanged elapids and viperids to the relatively nontoxic, rear-fanged colubrids. Venoms from colubrids and elapids demonstrated the greatest variation in cytotoxicity and were generally less toxic to both MCF-7 and A-375 cells. For the rear-fanged colubrids, this finding was not unexpected, as various colubrid toxins and venoms are prey-specific, showing high toxicity against lizards or birds, but not against mammals (Mackessy 2002; Mackessy et al. 2006; Pawlak et al. 2006 Pawlak et al. , 2009 Heyborne and Mackessy 2013) . This varying toxin-receptor specificity, which is associated with different prey types, likely also Numbers represents each of the 13 peaks obtained from cation exchange. a SDS-PAGE (reducing) analysis of each protein peak; protein family typically observed at given masses is indicated on the left. Note that phospholipases A 2 and threefinger toxins (3FTxs) dominate the proteome of P. porphyriacus venom. b Cytotoxicity of each peak toward MCF-7 breast cancer cells; peaks 1 and 13 (asterisks) were most potent. c Mass spectrogram of peak 1 peptides using a 5-16 kDa window; 3FTxs (6-7 kDa) and PLA 2 s (13-14 kDa) dominate. d Mass spectrogram of peak 13 peptides using a 5-16 kDa window; only PLA 2 (13,114.8 kDa) and trace amounts of a 3FTx are observed Cytotechnology (2016) 68:687-700 695 influences the cytotoxicity documented in this study. Further, this family of snakes has been taxonomically challenging, and currently defined families and subfamilies (formerly all in the family Colubridae) are believed to be distantly related (e.g., Gauthier et al. 2012; Pyron et al. 2013; Wiens et al. 2012) . It is therefore not unexpected that venom effects (and by extension composition) may vary significantly from the effects demonstrated by front-fanged snake venoms.
Viper venoms, on the other hand, tend to be quite toxic to a wide variety of prey (Gibbs and Mackessy 2009) , suggesting that specificity of these venoms may be less pronounced and that viper venoms contain a diversity of toxins that act against numerous prey sources. It is well known that rattlesnakes and other vipers undergo an ontogenetic shift in prey preference; neonates tend to prey on small ectothermic prey, whereas adults feed primarily on larger, more metabolically advantageous endothermic prey (e.g. Mackessy 1988) . This shift in prey preference is correlated with shifts in venom composition (Minton and Weinstein 1986; Mackessy 1988; Alape-Girón et al. 2008) , providing vipers with an arsenal of venom compounds with differing receptor specificities and toxicities. Rattlesnake venoms are also classified into type I (high metalloproteinase activity and lower toxicity) or type II (low metalloproteinase activity, high toxicity) venoms, as toxicity and metalloproteinase activity are generally inversely correlated (Mackessy 2008) .
Interestingly, our MTT assay results indicate that some venoms of high lethality to prey (including many of the elapid and viperid venoms evaluated) are not cytotoxic to cancer cells at doses assayed. For example, venom from C. o. concolor, which produces the most toxic venom (LD 50 = 0.4 mg/kg) within the viridis/ oreganus clade, and C. o. cerberus, which produces the least toxic venom (LD 50 = 5.4 mg/kg) of this clade (Mackessy 2010b) , showed a reverse relationship of cytotoxicity in our MCF-7 MTT assays (Fig. 6b, d ). Crotalus durissus terrificus (LD 50 = 0.13 mg/kg) and C. tigris (LD 50 = 0.07 mg/kg) venoms, which are among the most toxic of viper venoms, showed very low cytotoxicity toward MCF-7 cells (Fig. 1a) , while these same venoms showed variable cytotoxicity toward A-375 cells (Fig. 1b; C. tigris venom essentially noncytotoxic). Similarly, among Australian elapids, Acanthophis antarcticus venom (LD 50 = 0.34 mg/kg) and P. porphyriacus (LD 50 = 2.53 mg/kg) venom have very different whole animal toxicities (Mirtschin et al. 1990 ), but for both cell lines tested, Acanthophis venom was essentially non-toxic, while Pseudechis venom was potently cytotoxic. These data again underscore the difficulty in attempting to model whole animal toxicity by an alternative in vitro assay.
While most venoms demonstrated similar toxicity against both MCF-7 and A-375 cells, there were significant differences in the cytotoxicities of several venoms toward the two cell lines. Venom from the colubrid Ahaetulla nasuta, in particular, was non-toxic toward A-375 cells, but it was quite cytotoxic toward MCF-7 cells. Differences in ontogeny and phenotype between these cell lines may explain the discrepancies observed in this study, and several differences have been documented. Mammary gland cells are derived from embryologic mesenchyme, while melanocytes originate from cells of the neural crest. MCF-7 breast cancer cells are known to produce insulin-like growth factors (Takahashi and Suzuki 1993) and are responsive to estradiol, as they express cytoplasmic estrogen receptors. Further, MCF-7 cells express the WNT7B oncogene (Huguet et al. 1994) and also contain the Tx-4 oncogene. A-375 cells express melanocyte-stimulating hormone receptors, which are not expressed on MCF-7 cells (Sharma et al. 1996) . It is possible that differential expression of these (and other) receptors and oncogenes in the two cell types may be involved in the differential sensitivities observed.
Venoms that were highly cytotoxic, but which did not cause extensive cell lysis (as visualized by light microscopy) were of greatest interest for further characterization, because these venoms were suspected to contain fewer non-specific, highly toxic compounds. Venoms that demonstrated significantly greater toxicity than most other venoms within a family, and venoms that appeared to cause morphological changes in the cells, were also noted. Several viper venoms, from B. alternatus and Cryptelytrops (formerly Trimeresurus) purpureomaculatus purpureomaculatus, caused an intriguing change in A-375 cell morphology (see Fig. 5b-c) , while D. r. russelii venom (Fig. 5d) did not. Recently, the serine protease russelobin and the phospholipase A 2 RVAPLA 2 , both from D. r. russelii venom, were both demonstrated to lack cytotoxicity and did not induce morphological changes in MCF-7 or human colorectal adenocarcinoma (Colo-205) cells (Mukherjee and Mackessy 2013; Mukherjee 2014) ; however, an L-amino acid oxidase from the same venom showed potent cytotoxic effects toward MCF-7 cells (Mukherjee et al., in prep.) . The most striking effects on cell morphology were observed after treatment with venom from B. alternatus, a venom that consists predominantly (43 %) of P-III snake venom metalloproteases (SVMPs) but includes other common viperid venom compounds such as serine proteases, PLA 2 s, L-amino acid oxidases, disintegrins, and C-type lectins (Ö hler et al. 2010) . Additional studies will be necessary to determine which specific venom compound(s) lead to the morphological changes.
Pseudechis porphyriacus venom was chosen for further investigation for several reasons. This elapid venom demonstrated a high degree of cytotoxicity without causing massive cellular destruction, suggesting the presence of anti-proliferative and cytotoxic compounds that may have a degree of selectivity. In addition, P. porphyriacus venom showed a clear doseresponse curve (Fig. 6a) , suggesting that its cytotoxicity was due to specific venom components, rather than nonspecific factors producing cell necrosis associated with venom compounds, such as some SVMPs.
MCF-7 cells treated with fractioned P. porphyriacus venom showed varying degrees of cytotoxicity, with peaks 1 and 13 demonstrating the highest cytotoxicity. Based on SDS-PAGE and MALDI-TOF analysis, both peaks 1 and 13 contained proteins with masses characteristic of PLA 2 s. Peak 1 (acidic peptides) contained numerous proteins, including a 56 kDa protein (possible acetylcholinesterase), an acidic PLA 2 (mass = 14,048.3 Da) and several acidic three-finger toxins (3FTxs: masses of 6,648.2, 6,855.7 and 7,023.4 Da). Peak 13, containing a highly basic peptide that eluted during the high salt wash, consisted primarily of a basic PLA 2 (mass = 13,114.8 Da). Snake venom PLA 2 's have been shown to have a diversity of pharmacologic roles, including effects on cell proliferation and migration (Doley et al. 2009; Kini 2003) . Although some PLA 2 enzymes may not be cytotoxic (Mukherjee 2014) , it is likely that the cytotoxicity of peaks 1 and 13 is due to the presence of a specific PLA 2 . Three-finger toxins also show a wide variety of pharmacologies , including cytotoxicity, so the potential roles of these toxins in Peak 1 activity cannot be ruled out, but a similar sized (6,615 Da) three-finger toxin isolated from the same venom was demonstrated to show neurotoxic activity (Pierre et al. 2007 ). SVMPs also impact cultured cells, and some induce apoptosis (Fox and Serrano 2010; Masuda et al. 1998 Masuda et al. , 2000 Masuda et al. , 2001 . However, Pseudechis venom has quite low SVMP activity which is localized in peaks 5 and 7 (data not shown), and which are only modestly cytotoxic and essentially non-toxic, respectively.
Continued investigation of unusual venoms and lead compounds identified through this work has promise to yield novel peptides for further evaluation as pharmaceuticals, and more effective treatments for cancers or other human related disorders is a major goal of natural compound research. While the field of rational drug design has exploded in recent years, natural products remain an excellent source of incredibly diverse bioactive molecules with potential for development into therapeutics. Snake venoms, and especially those of the understudied rear-fanged colubrids, represent an undertapped resource of bioactive molecules with a wide variety of functions and potential applications (Saviola et al. 2014) . Through more extensive screening of this ''natural library'' of venom compounds, it is likely that a number of novel therapeutics will emerge.
Conclusion
We have shown that venoms from snakes of three distinct families have varying and sometimes exceptional levels of cytotoxicity towards MCF-7 and A-375 cell lines. Although a number of venoms with low cytotoxicity against both of these cell lines could be excluded from further investigation, specific compounds demonstrated significant anti-metastatic activity without undue cytotoxicity and should be investigated further. However, the many venoms that did show high cytotoxicity can be examined further for the compound(s) responsible for such effects and also warrant ongoing investigation. Our data suggest that compounds such as PLA 2 s and perhaps 3FTxs may be central to cytotoxic activities seen in P. porphyriacus venom, and the highly stable molecular scaffolds of these proteins may be of significant use for future therapeutic drug design (e.g. Fruchart-Gaillard et al. 2012) . To the best of our knowledge, this study represents the first cytotoxicity screening of many of the snake venoms tested and further illustrates the utility of snake venoms in biomedical research.
